Page last updated: 2024-08-17

benzimidazole and cyclopentane

benzimidazole has been researched along with cyclopentane in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Gonçalves, TP; Huang, KW; Jiang, Z; Li, Y; Qiao, B; Wang, G; Yin, Y; Zhan, Q; Zhao, X	1
Ann, J; Ha, HJ; Ha, JH; Hoang, VH; Jang, TH; Kim, H; Kim, YH; Lee, J; Ngo, VTH; Song, JY; Van Manh, N	1

Other Studies

2 other study(ies) available for benzimidazole and cyclopentane

Article	Year
All-Carbon Quaternary Stereocenters α to Azaarenes via Radical-Based Asymmetric Olefin Difunctionalization. Journal of the American Chemical Society, 2020, 11-18, Volume: 142, Issue:46 Topics: Alkenes; Aza Compounds; Benzimidazoles; Carbon; Catalysis; Cyclization; Cyclopentanes; Diphosphonates; Free Radicals; Imidazoles; Models, Molecular; Oxidation-Reduction; Photochemical Processes; Quinolines; Stereoisomerism; Thiazoles	2020
Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design. European journal of medicinal chemistry, 2021, Dec-15, Volume: 226 Topics: Alzheimer Disease; Aminoacyltransferases; Amyloid beta-Peptides; Animals; Benzimidazoles; Cyclopentanes; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred ICR; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship	2021

Article

Year

All-Carbon Quaternary Stereocenters α to Azaarenes via Radical-Based Asymmetric Olefin Difunctionalization.

Journal of the American Chemical Society, 2020, 11-18, Volume: 142, Issue:46

Topics: Alkenes; Aza Compounds; Benzimidazoles; Carbon; Catalysis; Cyclization; Cyclopentanes; Diphosphonates; Free Radicals; Imidazoles; Models, Molecular; Oxidation-Reduction; Photochemical Processes; Quinolines; Stereoisomerism; Thiazoles

2020

Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design.

European journal of medicinal chemistry, 2021, Dec-15, Volume: 226

Topics: Alzheimer Disease; Aminoacyltransferases; Amyloid beta-Peptides; Animals; Benzimidazoles; Cyclopentanes; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred ICR; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship

2021